|
A Multicenter, Observational, Open-Label, Single- Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients
|
Purpose: An observational study to determine which questionnaires and tests predict disease-free states for patients who are using Tysabri to treat early stages of Multiple Sclerosis.
For more information on this study, please visit: http://www.lahey.org/Departments_and_Locations/Departments/Neurology/Research/Multiple_Sclerosis_Trials.aspx
|
Principal Investigator(s):
Claudia J. Chaves, MD
For more information about this Research Study call 781-744-8027.
Study Coordinator(s):
Rik Ganguly.
|
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects with Secondary Progressive Multiple Sclerosis
|
Purpose: To determine whether or not Tysabri is effective in reducing disability progression for Secondary Progressive Multiple Sclerosis (SPMS) patients as compared to Placebo.
For more information on this study, please visit: http://www.lahey.org/Departments_and_Locations/Departments/Neurology/Research/Multiple_Sclerosis_Trials.aspx
|
Principal Investigator(s):
Ann Camac, MD
For more information about this Research Study call 781-744-8027.
Study Coordinator(s):
Rik Ganguly.
|